loading
전일 마감가:
$4.00
열려 있는:
$4.05
하루 거래량:
846.25K
Relative Volume:
0.58
시가총액:
$390.36M
수익:
$58.36M
순이익/손실:
$-25.72M
주가수익비율:
-10.79
EPS:
-0.3641
순현금흐름:
$-24.91M
1주 성능:
-1.01%
1개월 성능:
+20.92%
6개월 성능:
+26.77%
1년 성능:
+2.88%
1일 변동 폭
Value
$3.85
$4.07
1주일 범위
Value
$3.85
$4.30
52주 변동 폭
Value
$2.12
$5.80

Aquestive Therapeutics Inc Stock (AQST) Company Profile

Name
명칭
Aquestive Therapeutics Inc
Name
전화
908-941-1900
Name
주소
30 TECHNOLOGY DRIVE, WARREN, NJ
Name
직원
142
Name
트위터
Name
다음 수익 날짜
2025-03-05
Name
최신 SEC 제출 서류
Name
AQST's Discussions on Twitter

AQST을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
AQST
Aquestive Therapeutics Inc
3.93 397.31M 58.36M -25.72M -24.91M -0.3641
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
151.01 67.12B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.32 45.19B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.81 43.57B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.54 18.93B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.56 13.45B 2.99B 1.21B 1.13B 25.06

Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-02 재개 Oppenheimer Outperform
2024-12-17 개시 Cantor Fitzgerald Overweight
2024-05-10 개시 Leerink Partners Outperform
2024-04-11 개시 Piper Sandler Overweight
2024-03-28 개시 Raymond James Outperform
2021-04-07 재개 RBC Capital Mkts Outperform
2019-04-22 개시 H.C. Wainwright Buy
2019-01-03 개시 Lake Street Buy
2018-08-20 개시 JMP Securities Mkt Outperform
2018-08-20 개시 RBC Capital Mkts Outperform
모두보기

Aquestive Therapeutics Inc 주식(AQST)의 최신 뉴스

pulisher
Jul 29, 2025

Published on: 2025-07-29 20:47:23 - beatles.ru

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 19:03:19 - beatles.ru

Jul 29, 2025
pulisher
Jul 29, 2025

Aquestive's Anaphylm to be reviewed by Health Canada - MSN

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 10:12:06 - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-29 04:40:45 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Investors Hope for Bounce in Aquestive Therapeutics Inc. After SelloffTriple Digit Return Stock Predictions Released - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Is Aquestive Therapeutics Inc. a growth stock or a value stockSmart Portfolio Recommendation For Beginners - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why Aquestive Therapeutics Inc. stock attracts strong analyst attentionLow Risk Equity Screener With Results Shared - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What are the latest earnings results for Aquestive Therapeutics Inc.Rapid market gains - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Aquestive Therapeutics Inc. stock price move sharplyBreakout Stocks Tips For Beginners - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Aquestive Therapeutics Inc. generate profit in a changing economyOutperformance with explosive growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Should I hold or sell Aquestive Therapeutics Inc. stock in 2025Maximize gains with strategic stock entries - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Aquestive Therapeutics Inc.Unprecedented profit potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What institutional investors are buying Aquestive Therapeutics Inc. stockRemarkably fast returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Efficient Is Aquestive Therapeutics Inc. at Controlling Operating CostsBreakout Confirmation Tool - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

What is the dividend policy of Aquestive Therapeutics Inc. stockUnlock powerful portfolio optimization tools - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is Aquestive Therapeutics Inc. company’s balance sheetAccelerated investment success - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Is Aquestive Therapeutics Inc. a good long term investmentExceptional stock performance - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Aquestive Therapeutics Inc. stock priceDynamic growth stocks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Aquestive Therapeutics Inc. stock outlookTremendous gains - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Why Aquestive Therapeutics Inc. stock is on top investor watchlistsDynamic capital growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Should I buy Aquestive Therapeutics Inc. stock before earningsRapidly growing investment returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Aquestive Therapeutics Inc. Stock Analysis and ForecastBreakthrough investment results - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 22, 2025

What analysts say about Aquestive Therapeutics Inc. stockAccelerated profit realization - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

EpiPen Veteran to Lead Aquestive's Revolutionary Oral Epinephrine Launch as New Chief Commercial Officer - Stock Titan

Jul 22, 2025
pulisher
Jul 21, 2025

After Leaping 29% Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Are Not Flying Under The Radar - simplywall.st

Jul 21, 2025

Aquestive Therapeutics Inc (AQST) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$72.20
price down icon 0.29%
$14.39
price down icon 1.30%
$9.19
price down icon 0.76%
drug_manufacturers_specialty_generic RDY
$14.76
price up icon 0.41%
$134.19
price up icon 0.36%
$297.56
price down icon 0.19%
자본화:     |  볼륨(24시간):